Immunovant Newsroom

Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Cuts Target Price to $45

Futu News02:39

Immunovant Is Maintained at Overweight by Wells Fargo

Dow JonesDec 19 22:59

Immunovant Analyst Ratings

BenzingaDec 19 22:49

Wells Fargo Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $47

Futu NewsNov 20 19:32

H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $51

Futu NewsNov 9 01:32

A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $48 to $58

Futu NewsNov 8 21:15

Immunovant Price Target Maintained With a $51.00/Share by HC Wainwright & Co.

Dow JonesNov 8 19:27

Immunovant's Promising Pipeline and Strategic Advancements Justify Buy Rating

TipRanksNov 8 05:58

LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $51

Futu NewsNov 4 22:34

Promising Phase 2a Results for Immunovant's Batoclimab Support Buy Rating

TipRanksNov 4 21:37

LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $51

Futu NewsOct 19 02:31

Raymond James Maintains Immunovant(IMVT.US) With Buy Rating, Cuts Target Price to $36

Futu NewsOct 10 21:35

Raymond James Reinstates Outperform on Immunovant, Announces $36 Price Target

BenzingaOct 10 21:05

Immunovant Is Maintained at Outperform by Oppenheimer

Dow JonesOct 9 22:21

Immunovant Analyst Ratings

BenzingaOct 9 22:12

Oppenheimer Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53

Futu NewsOct 9 19:31

H.C. Wainwright Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $51

Futu NewsSep 30 18:31

LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $51

Futu NewsSep 24 22:31

Piper Sandler Maintains Immunovant(IMVT.US) With Buy Rating, Maintains Target Price $57

Futu NewsSep 13 04:31

A Quick Look at Today's Ratings for Immunovant(IMVT.US), With a Forecast Between $44 to $60

Futu NewsSep 10 21:00